In vitro antibiofilm activity of bioactive glass S53P4

Lorenzo Drago, Christian Vassena, Simone Fenu, Elena De Vecchi, Valentina Signori, Raffaele De Francesco, Carlo Luca Romanò

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Aim: This work aimed to investigate the ability of different formulations of bioactive glass (BAG)-S53P4 to interfere with bacterial biofilm produced on prosthetic material by methicillin-resistant Staphylococcus aureus and multi-drug-resistant Pseudomonas aeruginosa. Materials & methods: Antibiofilm activity of three formulations of bioglass was assessed at different time points through two different analyses: Crystal Violet and confocal laser scanning microscopy assays. Results: Significant differences in the whole biofilm were observed between BAG-S53P4-treated and control samples, while no marked changes in antibiofilm activity were observed among the tested formulations. Data from colorimetric assay were confirmed by confocal laser scanning microscopy analysis, which evidenced the significant reduction in biomass and a decrease of total cell volume when both S. aureus and P. aeruginosa biofilms were treated with BAG-S53P4. Conclusion: BAG-S53P4 can be considered as an excellent adjuvant in the treatment of prosthetic infections related to biofilm.

Original languageEnglish
Pages (from-to)593-601
Number of pages9
JournalFuture Microbiology
Volume9
Issue number5
DOIs
Publication statusPublished - 2014

Fingerprint

Biofilms
Confocal Microscopy
Pseudomonas aeruginosa
Gentian Violet
Methicillin-Resistant Staphylococcus aureus
Cell Size
Biomass
Staphylococcus aureus
bioactive glass S53P4
In Vitro Techniques
Infection
Pharmaceutical Preparations

Keywords

  • bacterial biofilm
  • bioactive glass
  • confocal laser scanning microscopy
  • prosthetic joint infections
  • prosthetic materials

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)
  • Medicine(all)

Cite this

Drago, L., Vassena, C., Fenu, S., De Vecchi, E., Signori, V., Francesco, R. D., & Romanò, C. L. (2014). In vitro antibiofilm activity of bioactive glass S53P4. Future Microbiology, 9(5), 593-601. https://doi.org/10.2217/fmb.14.20

In vitro antibiofilm activity of bioactive glass S53P4. / Drago, Lorenzo; Vassena, Christian; Fenu, Simone; De Vecchi, Elena; Signori, Valentina; Francesco, Raffaele De; Romanò, Carlo Luca.

In: Future Microbiology, Vol. 9, No. 5, 2014, p. 593-601.

Research output: Contribution to journalArticle

Drago, L, Vassena, C, Fenu, S, De Vecchi, E, Signori, V, Francesco, RD & Romanò, CL 2014, 'In vitro antibiofilm activity of bioactive glass S53P4', Future Microbiology, vol. 9, no. 5, pp. 593-601. https://doi.org/10.2217/fmb.14.20
Drago, Lorenzo ; Vassena, Christian ; Fenu, Simone ; De Vecchi, Elena ; Signori, Valentina ; Francesco, Raffaele De ; Romanò, Carlo Luca. / In vitro antibiofilm activity of bioactive glass S53P4. In: Future Microbiology. 2014 ; Vol. 9, No. 5. pp. 593-601.
@article{646ea1b573d842b7aadb212e5e9892d2,
title = "In vitro antibiofilm activity of bioactive glass S53P4",
abstract = "Aim: This work aimed to investigate the ability of different formulations of bioactive glass (BAG)-S53P4 to interfere with bacterial biofilm produced on prosthetic material by methicillin-resistant Staphylococcus aureus and multi-drug-resistant Pseudomonas aeruginosa. Materials & methods: Antibiofilm activity of three formulations of bioglass was assessed at different time points through two different analyses: Crystal Violet and confocal laser scanning microscopy assays. Results: Significant differences in the whole biofilm were observed between BAG-S53P4-treated and control samples, while no marked changes in antibiofilm activity were observed among the tested formulations. Data from colorimetric assay were confirmed by confocal laser scanning microscopy analysis, which evidenced the significant reduction in biomass and a decrease of total cell volume when both S. aureus and P. aeruginosa biofilms were treated with BAG-S53P4. Conclusion: BAG-S53P4 can be considered as an excellent adjuvant in the treatment of prosthetic infections related to biofilm.",
keywords = "bacterial biofilm, bioactive glass, confocal laser scanning microscopy, prosthetic joint infections, prosthetic materials",
author = "Lorenzo Drago and Christian Vassena and Simone Fenu and {De Vecchi}, Elena and Valentina Signori and Francesco, {Raffaele De} and Roman{\`o}, {Carlo Luca}",
year = "2014",
doi = "10.2217/fmb.14.20",
language = "English",
volume = "9",
pages = "593--601",
journal = "Future Microbiology",
issn = "1746-0913",
publisher = "Future Medicine Ltd.",
number = "5",

}

TY - JOUR

T1 - In vitro antibiofilm activity of bioactive glass S53P4

AU - Drago, Lorenzo

AU - Vassena, Christian

AU - Fenu, Simone

AU - De Vecchi, Elena

AU - Signori, Valentina

AU - Francesco, Raffaele De

AU - Romanò, Carlo Luca

PY - 2014

Y1 - 2014

N2 - Aim: This work aimed to investigate the ability of different formulations of bioactive glass (BAG)-S53P4 to interfere with bacterial biofilm produced on prosthetic material by methicillin-resistant Staphylococcus aureus and multi-drug-resistant Pseudomonas aeruginosa. Materials & methods: Antibiofilm activity of three formulations of bioglass was assessed at different time points through two different analyses: Crystal Violet and confocal laser scanning microscopy assays. Results: Significant differences in the whole biofilm were observed between BAG-S53P4-treated and control samples, while no marked changes in antibiofilm activity were observed among the tested formulations. Data from colorimetric assay were confirmed by confocal laser scanning microscopy analysis, which evidenced the significant reduction in biomass and a decrease of total cell volume when both S. aureus and P. aeruginosa biofilms were treated with BAG-S53P4. Conclusion: BAG-S53P4 can be considered as an excellent adjuvant in the treatment of prosthetic infections related to biofilm.

AB - Aim: This work aimed to investigate the ability of different formulations of bioactive glass (BAG)-S53P4 to interfere with bacterial biofilm produced on prosthetic material by methicillin-resistant Staphylococcus aureus and multi-drug-resistant Pseudomonas aeruginosa. Materials & methods: Antibiofilm activity of three formulations of bioglass was assessed at different time points through two different analyses: Crystal Violet and confocal laser scanning microscopy assays. Results: Significant differences in the whole biofilm were observed between BAG-S53P4-treated and control samples, while no marked changes in antibiofilm activity were observed among the tested formulations. Data from colorimetric assay were confirmed by confocal laser scanning microscopy analysis, which evidenced the significant reduction in biomass and a decrease of total cell volume when both S. aureus and P. aeruginosa biofilms were treated with BAG-S53P4. Conclusion: BAG-S53P4 can be considered as an excellent adjuvant in the treatment of prosthetic infections related to biofilm.

KW - bacterial biofilm

KW - bioactive glass

KW - confocal laser scanning microscopy

KW - prosthetic joint infections

KW - prosthetic materials

UR - http://www.scopus.com/inward/record.url?scp=84903303512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903303512&partnerID=8YFLogxK

U2 - 10.2217/fmb.14.20

DO - 10.2217/fmb.14.20

M3 - Article

C2 - 24957087

AN - SCOPUS:84903303512

VL - 9

SP - 593

EP - 601

JO - Future Microbiology

JF - Future Microbiology

SN - 1746-0913

IS - 5

ER -